BFG
ALNY icon

Bleakley Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bleakley Financial Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,590
Closed -$610K – 524
2024
Q4 		$610K Buy
2,590
+375
+17% +$98.6K 0.02% 562
2024
Q3 		$609K Buy
2,215
+439
+25% +$114K 0.02% 540
2024
Q2 		$432K Sell
1,776
-162
-8% -$25.6K 0.01% 650
2024
Q1 		$290K Sell
1,938
-88
-4% -$14.7K 0.01% 769
2023
Q4 		$388K Buy
2,026
+404
+25% +$68.8K 0.01% 656
2023
Q3 		$287K Sell
1,622
-234
-13% -$44.6K 0.01% 698
2023
Q2 		$353K Buy
1,856
+147
+9% +$29.1K 0.01% 680
2023
Q1 		$342K Sell
1,709
-197
-10% -$41.4K 0.01% 671
2022
Q4 		$453K Buy
+1,906
New +$407K 0.02% 575

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return